Login to Your Account

'Alphamer' Centauri: Start-up taking over anti-infective platform

By Nuala Moran
Staff Writer

Tuesday, January 19, 2016

LONDON – U.K. newco Centauri Therapeutics Ltd. has acquired the alphamer anti-infective technology inspired by Nobel Laureate and inventor of the polymerase chain reaction Kary Mullis, and raised £3 million (US$4.3 million) to complete preclinical development of the lead compound.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription